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Abstract: Phytochemical investigation of an ethanolic extract of stems of Schisandra 
neglecta led to the isolation and identification of two new dibenzocyclooctadiene lignans, 
designated neglschisandrins E (1) and F (2), and thirteen known lignans. All structures and 
stereochemistries were determined by spectroscopic methods, including 2D-NMR 
techniques. The isolates were evaluated for in vitro cytotoxic activity. Among them, 
compounds 2–6 exhibited moderate to weak cytotoxicity against the human colorectal 
carcinoma HCT-8 cell line with EC50 values of 7.33~19.8 μg/mL. In addition, compounds 
2–4 also exhibited marginal cytotoxicity against the human lung carcinoma A549 cell line 
with EC50 values of 11.8~15.0 μg/mL. 
Keywords: Schisandra neglecta; Schisandraceae; dibenzocyclooctadiene lignan; 
neglschisandrins E–F; cytotoxicity 
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Stems or fruits of plants in the Schisandraceae family are used widely in China as tonic and 
astringent agents for the treatment of rheumatic arthritis, traumatic injury, and related diseases [1]. 
Schisandraceae plants are rich in lignans, especially dibenzocyclooctadiene lignans, which show 
beneficial pharmacological effects, including anti-HIV, antitumor-promoting, calcium antagonistic, 
and anti-lipid peroxidative actions [2–13]. 
In our previous study, we reported four new dibenzocyclooctadiene lignans from the stems of 
Schisandra neglecta, which is indigenous to the Tibet Autonomous Region of China [14,15]. Our 
further investigation of the same plant has now led to the isolation and identification of two new 
dibenzocyclooctadiene lignans, named neglschisandrins E (1) and F (2) (Figure 1), together with 
thirteen known lignans, 6-O-benzoylgomisin O (3) [16], (+)-γ-rubschisandrin (4) [17], 
rubschisantherin (5) [17], benzoylisogomisin O (6) [18], schisandrin A (7) [19], schisanhenol (8) [20], 
angeloylgomisin H (9) [21], gomisin H (10) [21], tigloylgomisin H (11) [21], benzoylgomisin H  
(12) [21], schisandrin (13) [22], gomisin B (14) [23], and angeloyl-(+)-gomisin K3 (15) [24]. This 
paper reports the isolation and structural elucidation of these compounds as well as their in vitro 
cytotoxicity against human lung carcinoma A549 and human colorectal carcinoma HCT-8 cell lines. 










































2. Results and Discussion 
A 95% alcoholic extract prepared from stems of Schisandra neglecta was partitioned between 
diethyl ether and water. The diethyl ether extract was subjected to silica gel column chromatography 
(CC), preparative TLC, and semi-preparative reversed phase HPLC to give the two new and thirteen 
known dibenzocyclooctadiene lignans named above. 
Compound 1, obtained as amorphous powder, had the molecular formula C22H26O6 based on  
HR-ESI-MS (m/z 387.1810 [M+H]+). The UV and NMR spectra indicated that 1 was a 
dibenzocyclooctadiene lignan [25]. The 1H-NMR spectrum of 1 (Table 1) showed signals due to two 
secondary methyl groups (δH 0.97, 0.73, each 3H, d, J = 7.1 Hz), assignable to the cis-oriented Me-7 
and Me-8, respectively [26]. The presence of four benzylic methylene signals (δH 2.25, 1H, dd,  
J = 13.0, 9.6; 2.01 Hz, 1H, d, J = 13.0 Hz; 2.55, 1H, dd, J = 13.6, 7.4; 2.45 Hz, 1H, dd, J = 13.6, 1.5 Hz) 
indicated that C-6 and C-9 were unsubstituted. The 1H-NMR spectrum also showed signals for two 
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aromatic protons (δH 6.63, 6.49 each 1H, s), assignable to CH-4 and CH-11, respectively. Three 
methoxy groups [δH 3.50, 3.79 and 3.93, each 3H, s) and a methylenedioxy (–OCH2O–) moiety  
(δH 5.96, 5.95, each 1H, d, J = 1.3 Hz] were also observed as substituents on the aromatic rings. The 
proton signal at δH 5.68 (br s) showed no correlations in the HMQC spectrum, and was assigned as an 
hydroxyl on the aromatic ring. This assignment was supported by an IR band at 3447 cm−1 [27]. 
Table 1. 1H- (400 MHz) and 13C- (100 MHz) NMR data (measured in CDCl3) for 
compounds 1 and 2 (δ in ppm, J in Hz). 
 1 2 
Position δC δH δC δH 
   S  
1 150.3 (s) - 152.3 (s) - 
2 137.4 (s) - 139.9 (s) - 
3 148.8 (s) - 152.6 (s) - 
4 110.2 (d) 6.63 (s) 106.3 (d) 6.38 (s) 
5 140.3 (s) - 136.5 (s) - 
6 35.1 (t) 2.25 (dd, J = 9.6,13.0) 125.3 (t) 6.20 (s) 
  2.01 (d, J = 13.0)  - 
7 40.9 (d) 1.79 (m)  142.2 (s) - 
8 33.8 (d) 1.88 (m) 34.2 (d) 2.79 (m) 
9 38.9 (t) 2.55 (dd, J = 13.6,7.4) 42.9 (t) 3.10 (dd, J = 9,15.1) 
  2.45 (dd, J = 13.6,1.5)  2.38 (dd, J = 10.0,15.1) 
10 132.7 (s) - 135.3 (s) - 
11 106.2 (d) 6.49 (s)  111.5 (d) 6.57 (s) 
12 147.7 (s) - 151.6 (s) - 
13 135.1 (s) - 139.3 (s) - 
14 141.3 (s) - 142.5 (s) - 
15 122.5 (s) - 124.1 (s) - 
16 121.3 (s) - 122.1 (s) - 
17 21.8 (q) 0.97 (d, J = 7.1) 18.9 (q) 1.63 (s) 
18 12.4 (q) 0.73 (d, J = 7.1) 19.4 (q) 1.03 (d, J = 6.9) 
MeO-C (1) 60.1 (q) 3.50 (s) 60.7 (q) 3.61 (s) 
MeO-C (2) 61.0 (q) 3.93 (s) 60.8 (q) 3.84 (s) 
MeO-C (3) - - 55.9 (q) 3.83 (s) 
MeO-C (12) - - 55.9 (q) 3.88 (s) 
MeO-C (13) - - 60.7 (q) 3.80 (s) 
MeO-C (14) 59.7 (q) 3.79 (s) - - 
HO-C (3)  5.68 (br s)   - 
OCH2O 100.8 (t) 5.96, 5.95 (d, J = 1.3) - - 
Ang:1' - - 165.2 (s) - 
2' - - 127.8 (s) - 
3' - - 136.8 (d) 5.86 (m) 
4' - - 15.3 (q) 1.78 (s) 
5' - - 20.3 (q) 1.72 (d, J = 7.1) 
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HMBC correlations of CH-11 (δH 6.49) and methylenedioxy (δH 5.96, 5.95) protons with aromatic 
carbons at δC 147.7, 135.1 indicated that the methylenedioxy group was located at C-12 and C-13. 
Correlations of the CH-4 proton (δH 6.63) with carbons at δC 148.8 (C-3) and 137.4 (C-2) and of the 
hydroxyl proton at δH 5.68 with carbons at δC 110.2 (C-4), 148.8 (C-3) and 137.4 (C-2), indicated that 
the hydroxyl was located at C-3. Thus, the three methoxy groups were located at C-1, C-2, and C-14, 
based on HMBC correlations of the protons at δH 3.79, 3.93 and 3.50 with aromatic carbons at δC 
141.3 (C-14), 137.4 (C-2) and 150.3 (C-1), respectively. 
The circular dichroism (CD) spectrum of 1 showed a negative Cotton effect at 216 nm and a 
positive Cotton effect at 254 nm, which indicated an R-biphenyl configuration in 1 [28]. NOESY 
correlations between CH-11/Me-18, CH-4/CH-6α and CH-11/CH-9β indicated a twist-boat-chair 
(TBC) conformation for the cyclooctadiene ring [29] (Figure 2). The substituent positions and 
stereochemical assignments in the cyclooctadiene ring of 1 were further supported by NOESY 
correlations of MeO-1/MeO-14, Me-17/Me-18, CH-6β/Me-18 and CH-4/CH-7. Thus, the structure of 
1 was determined as that shown in Figure 1. Compound 1 and (−)-gomisin L2 have the same planar 
structure, but different stereochemistry [30]. 

















Compound 2, obtained as colorless powder, has the molecular formula C28H34O7 according to  
HR-ESI-MS (m/z 505.2187 [M+Na]+). Its IR, UV, CD and NMR data indicated that 2 is a also a 
dibenzocyclooctadiene lignan. The 1H-NMR spectrum of 2 (Table 1) showed the presence of five 
methoxy groups at δH 3.61, 3.80, 3.83, 3.84 and 3.88 (each 3H, s), and an angeloyl group at δH 5.86 
(1H, m), 1.78 (3H, s), 1.72 (3H, d, J = 7.1 Hz) on aromatic rings [24]. 
The following proton-carbon HMBC correlations were observed: CH-4 (δH 6.38) with C-3  
(δC 152.6) and C-2 (δC 139.9), CH-11 (δH 6.57) with C-12 (δC 151.6), C-13 (δC 139.3) and C-14  
(δC 142.5), and the five methoxy signals at δH 3.61, 3.84, 3.83, 3.88 and 3.80 with aromatic carbon 
signals at δC 152.3 (C-1), 139.9 (C-2), 152.6 (C-3), 151.6 (C-12) and 139.3 (C-13), respectively. These 
correlations indicated that the five methoxy groups were attached to C-1, C-2, C-3, C-12, and C-13, 
and the angeloyl group was located at C-14 (Figure 3).  
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Furthermore, the 1H-NMR spectrum of 2 showed a proton signal at δH 6.20 (1H, s) and the  
13C-NMR spectrum showed a quaternary olefinic carbon at δC 142.2 and a methine olefinic carbon at 
δC 125.3, suggesting the formation of a double bond. A singlet methyl signal at δH 1.63 (3H, s, Me-17) 
in the 1H-NMR spectrum indicated that the double bond was located between C-6 and C-7 and was 
substituted with a methyl group. HMBC correlations of δH 6.38 (CH-4) with δC 125.3 (C-6), δH 6.20 
(CH-6) with δC 136.5 (C-5), 122.1 (C-16) and 18.9 (C-17), δH1.63 (Me-17) with δC 142.2 (C-7) and 
34.2 (C-8), δH 2.38 and 3.10 (CH2-9) with δC 142.2 (C-7) confirmed the substructure. 
The CD spectrum of 2 had a negative Cotton effect at 219 nm and a positive Cotton effect at 251 
nm, indicating that 2 has an R-biphenyl configuration. The NOESY correlations between CH-4/CH-6, 
CH-6/Me-17, and CH-11/CH-9β, CH-9α/CH-8, CH-11/MeO-12, CH-9β/Me-18, and Me-17/Me-18 fully 
supported the assigned structure and stereochemistry (Figure 4). Compound 2 has an endocylic double 
bond rather than the exocyclic double bond found in the previously reported neglschisandrin B [14]. 










The lignans were evaluated in vitro for cytotoxicity against human lung carcinoma A549 and 
human colorectal carcinoma HCT-8 cell lines employing a MTT-assay with paclitaxel as the positive 
control (Table 2). Five lignans exhibited moderate cytotoxicity, while the remaining lignans showed no 
activity. Against HCT-8, compounds 3 and 6 showed moderate cytotoxicity (EC50 9.58 and 7.33 μg/mL, 
respectively); compounds 2 and 4 exhibited marginal cytotoxicity (EC50 13.8 and 12.6 μg/mL, 
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respectively), and compound 5 showed weak cytotoxicity (EC50 19.6 μg/mL). Against A549, 
compounds 2–4 exhibited marginal cytotoxicity with EC50 values ranging from 11.8 to 15.0 μg/mL.  
Table 2. Cytotoxicity data of lignans from Schisandra neglecta. 
Compound 
Cytotoxicity (EC50, μg/mL) 
HCT-8 A549 
2 13.8 11.8 
3 9.58 13.8 
4 12.6 15.09 
5 19.8 NA a 
6 7.33 NA a 
Paclitaxel 0.21 <0.005 
a NA (not active)--test compound (20 μg/mL) did not reach 50% inhibition. 
3. Experimental 
3.1. General 
Optical rotations: P-1020 digital spectropolarimeter (JASCO) with MeOH as solvent. UV spectra: 
Hitachi U-3010 spectrophotometer in MeOH; λmax (log ε) in nm. 
1H-, 13C-, 2D-NMR spectra: Bruker 
DRX400 (400 MHz for 1H, 100 MHz for 13C) spectrometer in CDCl3; δ in ppm rel. to Me4Si as internal 
references. J in Hz. ESI mass: Bio TOF Q spectrometer; in m/z (rel. %). HR-ESI-MS: Bruker 
Daltonics BioToF-ШQ mass spectrometer in positive-ion mode (Bremen, Germany). IR spectra: 
Avatar Thermo Nicolet 360-ESP spectrophotometer. TLC was performed on silica gel plates GF254 
(Yantai Institute of Chemical Technology, Yantai, China). The TLC spots were visualized by UV light 
(254 nm) and sprayed with 10% H2SO4, followed by heating. Column chromatography (CC) was 
carried out on silica gel (200–300 mesh or 300–400 mesh Qingdao Marine Chemical Factory, 
Qingdao, China). Semi-prep HPLC was carried out on an octadecylsilane column (RP-18, 250 × 10 mm, 
10 μm, YMC, detector: Amersham UV-900) with a flow rate of 3.0 mL/min. 
3.2. Plant Material 
Stems of Schisandra neglecta were collected in Lin-zhi County, Tibet Autonomous Region, 
People’s Republic of China in September of 2004, and identified by Professor Hong-ping Deng, 
School of Life Sciences, Southwest University. A voucher specimen (MC-LZ-040901) is deposited in 
the Herbarium of Medicinal Plant, School of Life Sciences, Southwest University, Chongqing, China. 
3.3. Extraction and Isolation 
Powdered air-dried stems (5.0 kg) of Schisandra neglecta were extracted exhaustively with 95% 
EtOH (5 × 10 L, each three days) at room temperature. The alcoholic extract was evaporated in vacuo 
to yield a semisolid (430 g), which was suspended in water (1,000 mL) and extracted five times with 
diethyl ether. The organic solution was concentrated to yield 112 g of residue, which was subjected to 
silica gel CC eluted with petroleum ether/acetone mixtures of increasing polarity (99:1 to 3:7) to 
obtain ten fractions. Fraction 3 (8.3 g), eluted with petroleum ether–acetone (95:5), gave 7 (1.2 g), and 
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then was further chromatographed with silica gel CC eluting with petroleum ether/CHCl3 (9:2) to 
obtain six subfractions. Subfraction 3–3 (1.3 g) was subjected to preparative TLC with petroleum 
ether/CHCl3 (1:1) to yield 4 (14 mg). Fraction 4 (7.4 g), eluted with petroleum ether/acetone (9:1), was 
subjected to CC with petroleum ether/EtOAc (15:1~4:1) to obtain eight subfractions. Subfraction 4–3 
(0.5 g) was purified by preparative HPLC with MeOH/H2O (70:30) to yield 5 (4 mg, RT 25.3 min) and 
6 (10 mg, RT 31.1 min). Subfraction 4–4 (0.7 g) was subjected to preparative TLC with petroleum 
ether/CHCl3 (1:1) to yield 3 (17 mg). Subfraction 4–5 (0.3 g) was purified by semi-preparative HPLC 
with MeOH-H2O (70:30) to yield 1 (2 mg, RT 33.4 min). Subfraction 4–6 (3.2 g) was subjected to 
silica gel CC with petroleum ether-EtOAc (5:1) to yield 8 (2.3 g). Fraction 5 (6.7 g) eluted with 
petroleum ether-acetone (8:2) was subjected to silica gel CC with petroleum ether/EtOAc (10:2–5:2). 
Subfraction 5–2 (0.6 g) was purified by semi-preparative HPLC with MeOH/H2O (75:25) to yield 9 
(32 mg, RT 37.5) and 15 (46 mg, RT 40.2). Subfraction 5–3 (1.7 g) was subjected to silica gel CC with 
petroleum ether/EtOAc (9:2), then purified by semi-preparative HPLC with MeOH/H2O (64:36–80:20) 
to yield 10 (4 mg, RT 25.6 min), 11 (10 mg, RT, 28.7 min), and 12 (43 mg, RT 37.9 min), Subfraction 
5–5 (0.9 g) was subjected to silica gel CC with petroleum ether/CHCl3 (5:6), and further purified by 
semi-preparative HPLC with MeOH/H2O (7:3) to yield 13 (24 mg, RT 40.3 min) and 14 (19 mg, RT 
44.5 min). Fraction 6 (5.2 g) eluted with petroleum ether-acetone (7:3) was subjected to silica gel CC 
with petroleum ether/EtOAc (10:3). Subfraction 6–3 (0.7 g) was purified by semi-preparative HPLC 
with MeOH-H2O (75:25 to 85:15) to yield 2 (10 mg, RT 24. 7 min). 
6R,7S,R-biar-[5,6,7,8-Tetrahydro-1,2,13-trimethoxy-6,7-dimethyl-benzo-[3',4']cycloocta[1',2':4,5]-
benzo[1,2-d][1,3]dioxol-3-ol (neglschisandrin E, 1). White amorphous powder; [α]22D +26.9°  
(c = 0.26, MeOH). UV (MeOH): 216 (4.67), 250 (4.22), 280 (3.97). CD (c = 0.08, MeOH), [θ]15 (nm): 
−28275 (216), +28636 (254). IR (KBr): 3447, 2925, 1615, 1585, 1476, 737. 1H-NMR and 13C-NMR: 
see Table 1. HR-ESI-MS: found 387.1810 ([M+H]+, C22H27O6
+, calc. 387.1808). 
5Z,7R,R-biar-7,8-Dihydro-1,2,3,10,11-pentamethoxy-13-(2Z)-methylbut-2-enoyl-6,7-dimethyl-dibenzo 
[a,c]cycloocten-5(6H)-one (neglschisandrin F, 2). White amorphous powder; [α]22D +16.9° (c = 0.31, 
MeOH). UV (MeOH): 216 (4.78), 250 (4.37), 279 (3.97). CD (c = 0.052, MeOH), [θ]15 (nm): −295132 
(219), +155445 (251). IR (KBr): 3404, 2936, 1737, 1636, 1591, 1488, 734. 1H-NMR and 13C-NMR: 
see Table 1. HR-ESI-MS: found 505.2187 ([M+Na]+, C28H34NaO7
+, calc. 505.2197). 
3.4. Cytotoxicity Assay 
Freshly trypsinized cell suspensions were seeded in 96-well microtiter plates at densities of  
5,000–10,000 cells per well with compounds added from DMSO-diluted stock. After three days in 
culture, attached cells were incubated with cold 10% trichloroacetic acid (MTT, 0.5 mg/mL, 2 h) and 
subsequently solubilized in DMSO, and the isolates were tested against A549 and HCT-8 cancer cell 
lines using established colorimetric MTT assay protocols [31]. Paclitaxel was used as a positive 
control. All stock cultures were grown in T-25 flasks. The mean EC50 is the concentration of agent that 
reduces cell growth by 50% under the experimental conditions and is the average from at least three 
independent determinations that were reproducible and statistically significant. The absorbance was 
measured at 550 nm using a microplate reader. 




Two new lignans, neglschisandrins E and F (1 and 2, respectively), and thirteen known lignans 
were isolated from stems of Schisandra neglecta. Their structures and stereochemistries were 
established by means of NMR and ESI-MS analyses, including 2D-NMR techniques. The isolates 
were evaluated for in vitro cytotoxic activity. Compounds 2–6 showed cytotoxicity against the human 
HCT-8 colorectal carcinoma cell line with EC50 values of 7.33~19.8 μg/mL, while compounds 2–4 
also exhibited cytotoxicity against the human A549 lung carcinoma cell line with EC50 values of 
11.8~15.0 μg/mL, respectively. Since other dibenzocyclooctadiene lignans in the genus Schisandra 
exhibit proven antitumor activities [32], further research to identify related potent cytotoxic 
compounds or explore detailed structure-activity relationships is merited. 
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